Small Cap Profile: Renalytix (RNLX) has Transformational Potential in Kidney Diagnostics Mar 09, 2021 Renalytix AI (RNLX) is a UK-based company that came public in June of 2020, and is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical... read more